HoLEP effective for overactive bladder symptoms
Research shows that Holmium laser enucleation of the prostate is effective in improving overactive bladder symptoms and urodynamic parameters in men with benign prostatic hyperplasia. (Source: MedWire News - Urology)
Source: MedWire News - Urology - January 13, 2014 Category: Urology & Nephrology Source Type: news
PTNS Efficacy in Treating Lower Urinary Tract DysfunctionsPTNS Efficacy in Treating Lower Urinary Tract Dysfunctions
How effective is percutaneous tibial nerve stimulation in treating overactive bladder and other urological conditions? BMC Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - January 6, 2014 Category: Urology & Nephrology Tags: Urology Journal Article Source Type: news
Volunteering for Clinical Trials – the patient’s perspective
Volunteering for clinical trials is always something that requires a great deal of thought and it’s often motivated by a personal experience of health issues and a desire to prevent problems for others in the future. Shirley Dimblebee is a regular participant and she shares her experiences and reasons with us as an encouragement for others to help out too.
Why did you decide to participate in clinical trials?
My husband had prostate cancer and he had medication to keep him as pain free as possible before he sadly passed away.
Some months later I listened to a radio programme about clinical trials and the need for hea...
Source: The Hysterectomy Association - November 29, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Latest News clinical trials covance Source Type: news
Efficacy of Mirabegron for Overactive BladderEfficacy of Mirabegron for Overactive Bladder
Mirabegron may be an effective therapeutic option for OAB patients who may not benefit from antimuscarinic therapy. BMC Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2013 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Botox for Overactive Bladder, Same Cost as AnticholinergicsBotox for Overactive Bladder, Same Cost as Anticholinergics
Although the up-front cost of onabotulinumtoxin A is higher than a daily anticholinergic, the efficacy and safety of the 2 therapies balance out, say researchers. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2013 Category: Consumer Health News Tags: Urology News Source Type: news
Botox for overactive bladder approved for Scotland
The Scottish Medicines Consortium (SMC) has approved botulinum toxin type A (Botox) as a treatment for urinary incontinence in adults who have an overactive bladder due to multiple sclerosis, where the current medication has not been effective. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - October 8, 2013 Category: Neurology Source Type: news
OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women, Now Available Nationwide
Dateline City:
WHITEHOUSE STATION, N.J.
Offers More Than 20 Million Female Sufferers Newfound Sense of Control over Condition
Merck Consumer Care, the makers of OXYTROL FOR WOMEN, announced today that the more than 20 million women suffering from overactive bladder (OAB) can now gain better control of their condition with a visit to the feminine care aisle at their local retailer. OXYTROL FOR WOMEN is a thin, flexible patch that is discreetly applied to the abdomen, hip or buttock once every four days for the ...
Source: Merck.com - Corporate News - September 25, 2013 Category: Pharmaceuticals Tags: Merck Merck Consumer Care MRK MSD OAB overactive bladder Oxytrol Consumer Care News Corporate News Latest News Source Type: news
Now anti-wrinkle jab Botox is used to treat dysfunctional bladders
The UK drugs regulator has ruled that those with an overactive bladder should have access to Botox if other methods of control prove ineffective. (Source: the Mail online | Health)
Source: the Mail online | Health - September 24, 2013 Category: Consumer Health News Source Type: news
Post hoc analysis suggests that BETMIGA™ may relieve overactive bladder symptoms where prior antimuscarinic treatment has failed
BETMIGA™ (mirabegron), a new oral treatment for overactive bladder, has the potential to provide relief for patients who have discontinued prior treatment due to insufficient efficacy or poor tolerability according to a post hoc analysis of the Phase III EU/Australian study.[1] The analysis investigated whether the benefits of mirabegron seen in a randomised, double-blind, placebo- and active-controlled Phase III study[2] were experienced by both treatment-naïve patients and those who had discontinued previous antimuscarinic treatment... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news
NICE backs Botox for overactive bladder
Women with overactive bladder syndrome should be offered treatment with Botox in some cases, according to guidance from the National Institute for Health and Care Excellence. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - September 12, 2013 Category: Nursing Source Type: news
Options for women with urinary incontinence
New methods of managing urinary incontinence have become available on the NHS since the publication of NICE's 2006 guideline, with botulinum toxin A now more commonly used for treating overactive bladder (OAB) symptoms.
This updated guidance recommends offering bladder wall injection with botulinum toxin A to women with OAB caused by proven detrusor overactivity that has not responded to conservative management, which includes OAB drug therapy. (Source: NHS Networks)
Source: NHS Networks - September 12, 2013 Category: UK Health Authors: Karen Topping Source Type: news
Overactive bladder leads to underactive patients
Researchers in the USA have shown that patients with overactive bladder experience significant impairment to their physical activity levels. (Source: MedWire News - Urology)
Source: MedWire News - Urology - September 4, 2013 Category: Urology & Nephrology Source Type: news
UI undertreatment ‘prevalent in care homes’
Researchers say that there may be a substantial proportion of residents in long-term care facilities with urinary incontinence due to overactive bladder who could benefit from antimuscarinic treatment. (Source: MedWire News - Urology)
Source: MedWire News - Urology - August 26, 2013 Category: Urology & Nephrology Source Type: news
Bedwetting treatment starts with open communication
by Scott Howe
“He was 8 years old and still wearing diapers. We knew he had a problem.” – Mother of a boy with a bedwetting issue
“It really wasn’t difficult to talk about her wetting as she knew something was wrong. We concentrated on making her comfortable and assuring her all would be fine.” – Mother of a young girl with a wetting problem
Urinary incontinence, otherwise known as “enuresis” or “wetting,” is fairly common, often embarrassing and sometimes difficult to talk about it. Of children 6 to 7, about 20 percent of boys and 17 percent of girls have some problem with daytime or nighttime ...
Source: Thrive, Children's Hospital Boston - August 22, 2013 Category: Pediatrics Authors: Guest Blogger Tags: All posts acupuncture Bed wetting biofeedback training Carlos Estrada Reiki therapy urinary tract infections Voiding Improvement Program Source Type: news
